169361 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors CNS-stimulants, e.g. cocaine, amphetamines
CHEMICAL SENSORS EMPLOYING pH-SENSITIVE APTAMERS
#2READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION OF ANALYTES IN BIOLOGICAL SAMPLES
#3METHOD FOR DETERMINING HEROIN
#4UTILIZING TRACE AMOUNTS OF A SUSPECTED TARGET MOLECULE AS A CATALYST IN DETECTION REACTIONS
#5NUCLEIC ACID PROBE, CHEMICAL SENSOR, AND DETECTION METHOD
#6BROAD SPECTRUM DETECTION KITS
#7DETECTION APPARATUS FOR DETECTING ANALYTE IN A LIQUID SAMPLE AND METHOD THEREOF
#8Capillary Microsample Analysis Methods
#9BIOLOGICAL AND/OR BIOCHEMICAL AND/OR CHEMICAL SENSOR
#10DETECTION PLATFORM AND METHOD FOR DETECTING ABUSED DRUGS
#11Arylalkylamine, pyrrole, indole, and opiate derivative concentration determination method and test kit using said method
#12DNA aptamer-cyanine complexes as mephedrone and cannabinoid colorimetric sensors
#13Methods of rational nicotine hapten design and uses thereof
#14APPARATUS FOR DETECTING ANALYTE IN A LIQUID SAMPLE AND METHOD THEREOF
#15Apparatus and method for determination of banned substances
#16Process for making levoamphetamine
#17CONSUMER OPERATED ANALYSIS OF CANNABIS BASED PRODUCTS AND OTHER PRODUCTS, RELATED DATA PROCESSING, SYSTEMS AND METHODS THEREOF
#18HOMOGENEOUS ENZYME IMMUNOASSAY FOR KERATINIZED STRUCTURES
#19Detection apparatus for detecting analyte in a liquid sample and method thereof
#20Apparatus for collecting and detecting an analyte in a fluid sample
#21POINT-OF-COLLECTION GRAPHENE-BASED TOXICOLOGY SENSOR
#22Colorimetric drug test strip using porous support material
#23HOMOGENEOUS ENZYME IMMUNOASSAY FOR KERATINIZED STRUCTURES
#24Detecting an analyte in the presence of an interferent
#25Functional ligands to drug compounds
#26Methods for generating structure-switching aptamers and uses thereof
#27Apparatus for collecting and detecting an analyte in a fluid sample
#28Materials and methods for rapid and sensitive detection of small-molecule targets
#29Rapid and sensitive method of forensic toxicology in post-mortem subjects and in live and post-mortem animals using oral fluid testing
#30Oral fluid collector
#31Rapidly configurable drug detection system with enhanced confidentiality
#32METHOD AND DEVICE FOR MONITORING MEDICATION USAGE
#33Detection apparatus for detecting analyte in a liquid sample and method thereof
#34Immunoassay for phenethylamines of the 2C and DO sub-families
#35Fluorescence-based chemical detection of amine-based substances
#36Methods of rational nicotine hapten design and uses thereof
#37Cocaine aptamer and method for detecting cocaine using the same
#38Cocaine aptamer and method for detecting cocaine using the same
#39Electrochemical aptasensors with a gelatin B matrix
#40Apparatus for detecting analyte in a liquid sample and method thereof
#41READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION
#42Transformed response potentiometric titrations
#43Electrochemical aptasensors with a gelatin B matrix
#44Methods of rational nicotine hapten design and uses thereof
#45Method and Device for Monitoring Medication Usage
#46Cartridge for assays with magnetic particles
#47Small molecule-dependent split aptamer ligation
#48Systems and methods for distinguishing cotinine from anabasine in a point-of-care testing device
#49Materials and methods for rapid and specific detection of cocaine
#50Immunoassay for pyrrolidinophenones
#51DEVICES AND METHODS FOR DETECTING AND/OR QUANTIFYING ANALYTES IN FLUIDS
#52Immunoassay for compounds of the NBOMe family
#53Integrity testing of hair samples
#54METAL NANOPARTICLE-APTAMER CONJUGATES FOR DETECTION OF SMALL MOLECULES AND IN-THE-FIELD USE THEREOF
#55Test kit for the quantitative determination of narcotic drugs
#56Methods for determining ligand binding to a target protein using a thermal shift assay
#57SAMPLING MEDIUM
#58Small molecule-dependent split aptamer ligation
#59Integrity testing of hair samples
#60Immunoassay for phenethylamines of the 2C and DO sub-families
#61DETECTING ANALYTES WITH A PH METER
#62METHOD AND DEVICE FOR DETECTING ANALYTES
#63Method and Device for Monitoring Medication Usage
#64COLORIMETRIC METHOD TO DETECT ILLICIT DRUGS
#65Sensor cartridge for detecting component of at least one sample
#66FLUORESCENCE IMMUNOASSAY USING POLYPEPTIDE COMPLEX CONTAINING FLUORO-LABELED ANTIBODY VARIABLE REGION
#67Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use
#68Device and methods for detecting analytes in saliva
#69Bio-nano-chips for on-site drug screening
#70Methods for determining ligand binding to a target protein using a thermal shift assay
#71Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#72METHODS FOR QUANTITATIVE CHIRAL DETERMINATION OF THE d- AND l- ENANTIOMERS OF AMPHETAMINE AND METHAMPHETAMINE
#73Small molecule-dependent split aptamer ligation
#74Urinalyisis test for synthetic canabanoids
#75Assay method for detecting primary amines
#76NOVEL MARKERS FOR DIAGNOSING BRAIN DISEASE CAUSED BY BRAIN INJURY AND USE THEREOF
#77NOVEL METHOD FOR SCREENING BRAIN-ACTIVE COMPOUNDS
#78METHOD AND DEVICE FOR MONITORING MEDICATION USAGE
#79Device and methods for detecting analytes in saliva
#80CARTRIDGE FOR ASSAYS WITH MAGNETIC PARTICLES
#81Salvinorin immunoassay
#82Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#83Method and device for monitoring medication usage
#84METHOD AND KIT FOR DETECTING, OR DETERMINING 3,4- METHYLENEDIOXYMETHAMPHETAMINE
#85POSITIVE DETECTION LATERAL-FLOW APPARATUS AND METHOD FOR SMALL AND LARGE ANALYTES
#86Caffeine detection via internally-referenced two part assay
#87Method for the presumptive detection of substances
#88COMPOSITIONS AND METHODS FOR COMBINING REPORT ANTIBODIES
#89Detection of methamphetamine group drugs
#90Systems and methods for molecular recognition
#91Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#92Antibody profiling sensitivity through increased reporter antibody layering
#93Immunoassay for LSD and 2-oxo-3-hydroxy-LSD
#94Methods for determining the feeding habits of an animal
#95Novel mediator of neurotransmitter and psychostimulant responses
#96Non-competitive immunoassay for small analytes
#97Methods and compositions for treatment of central nervous system disorders
#98Positive detection lateral-flow apparatus and method for small and large analytes
#99Coated metal surface on solid support for analyte detection by displacement
#100Simultaneous screening of multiple analytes
#101Method for retrieving delta9-THC from oral fluid
#102Systems and methods for molecular recognition
#103System, device and method for detection of several individual analytes in a solution, and a disposable flow cell for use therein
#104Assays for amphetamine and methamphetamine
#105Assays for amphetamine and methamphetamine using stereospecific reagents
#106Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
#107Methods for treating drug addiction
#108Method for the detection of compounds comprising methylenedioxyphenyl
#109Assay for entactogens
#110Assay for entactogens
#111Ecstasy haptens and immunogens
#112Method and device for monitoring medication usage
#113Composition and processes for analysis of pharmacologic agents in biological samples
#114Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
#115Devices and methods to monitor HIV-infection in presence of substance of abuse and/or therapeutic agent
#116Mass produced, low cost, portable test kit for the detection and identification of narcotics